Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol.
Saved in:
| Title: | Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol. |
|---|---|
| Authors: | Toh TB; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore., Thng DKH; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore., Bolem N; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore., Vellayappan BA; Department of Radiation Oncology, National University Cancer Institute, Singapore, Singapore., Tan BWQ; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore., Shen Y; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore., Soon SY; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore., Ang YLE; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore., Dinesh N; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore., Teo K; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore., Nga VDW; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore., Low SW; Division of Neurological Surgery, Ng Teng Fong General Hospital, Singapore, Singapore., Khong PL; Department of Diagnostic Imaging, National University Hospital, Singapore, Singapore.; Clinical Imaging Research Centre (CIRC), National University of Singapore, Singapore, Singapore., Chow EK; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore., Ho D; The N.1 Institute for Health (N.1), National University of Singapore, Singapore, Singapore.; The Institute for Digital Medicine (WisDM), National University of Singapore, Singapore, Singapore., Yeo TT; Division of Neurosurgery, Department of Surgery, National University Hospital, Singapore, Singapore., Wong ALA; Cancer Science Institute of Singapore (CSI), National University of Singapore, Singapore, Singapore.; Department of Haematology-Oncology, National University Hospital, Singapore, Singapore. |
| Source: | PloS one [PLoS One] 2024 Jul 26; Vol. 19 (7), pp. e0307818. Date of Electronic Publication: 2024 Jul 26 (Print Publication: 2024). |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0307818 |
